FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-944 | 69194-944-01 | Epinephrine | .1 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-976 | 69194-976-10 | Epinephrine | 4 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-975 | 69194-975-10 | Epinephrine | 8 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-977 | 69194-977-10 | Epinephrine | 5 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Epinephrine; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-886 | 69194-886-01 | Fentanyl Citrate | 10 ug/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Foscarnet Sodium | 2.4 mg/.1 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-887 | 69194-887-01 | Ketamine Hydrochloride | 2.5 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-909 | 69194-909-01 | Lidocaine Hydrochloride | 40 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-908 | 69194-908-01 | Lidocaine Hydrochloride | 20 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 40 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-802 | 69194-802-01 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-585 | 69194-585-01 | Moxifloxacin Hydrochloride | 100 ug/.1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-553 | 69194-553-01 | Moxifloxacin Hydrochloride | 150 ug/.1 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 32 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-115 | 69194-115-10 | Norepinephrine Bitartrate | 4 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-119 | 69194-119-10 | Norepinephrine Bitartrate | 16 mg/250 mL | 2024-2 | valid | 2026-11-02 | ||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 500000 U/500 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 15000 U/1500 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 500000 ug/5000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 240000 ug/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1 mg/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 400 ug/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 50 mg/250 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1 mg/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 20 mg/250 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 1000 ug/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 300000 ug/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 15000 mg/1500 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 800 ug/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 40 mg/250 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine | 120000 ug/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine Hydrochloride | 6000 mg/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine; Epinephrine; Clonidine; Ketorolac | 7380 mg/3000 mL; 15 mg/3000 mL; 2.4 mg/3000 mL; 900 mg/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Sodium Bicarbonate | 50 meq/50 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Sodium Bicarbonate | 3000 meq/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60000 mg/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 100 mg/5 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 200 mg/10 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2000 mg/20 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 300000 mg/3000 mL | 2024-2 | source_no_ndc | 2026-11-02 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 500 g/5000 mL | 2024-2 | source_no_ndc | 2026-11-02 |